CT in $33M multistate settlement on over-the-counter drug quality

Posted May 25, 2017

Johnson & Johnson will pay $33 million to IL and at least 40 other states to settle allegations that a subsidiary falsely claimed it was following federal manufacturing practices - a situation the states said led to the recall of common drugs including Tylenol, Motrin, Benadryl and Sudafed.

Florida's share of a settlement with Johnson & Johnson over adulterated over-the-counter drugs will exceed $1.6 million, Attorney General Pam Bondi announced Wednesday.

The settlement requires Johnson & Johnson to pay a total of $33 million, which is being divided among the District of Columbia and the 42 states that joined in the case. McNeil-PPC, Inc. was a wholly-owned subsidiary of Johnson & Johnson that manufactured and distributed over-the-counter (OTC) drugs.

More news: Trump says Palestinian and Israeli leaders ready to 'reach for peace'

West Virginia will receive more than $440,000 from the settlement, according to Morrisey.

The lawsuit also claimed McNeil unlawfully promoted its products because the drugs were not manufactured in compliance with federal requirements.

"It's critical that companies meet good manufacturing practices and protect product quality", Attorney General Patrick Morrisey said in the release.

More news: United Fresh releases statement on NAFTA renegotiation

The settlement prohibits McNeil from stating its facilities meet federal standards within 12 months of a recall.

"Hundreds of millions" pf packages of popular brands like Tylenol, Benadryl, Pepcid, and Rolaids produced at McNeil's Fort Washington, PA from 2009 to 2011 were recalled in response to reports of "product oddities" like strange odors and particles in some of the products, the Pennsylvania Office of the Attorney General said in a press release heralding the settlement.

"This is common sense", Attorney General Eric Schneiderman of Consumerist's home state of NY said in a statement sent this afternoon.

More news: Sasheer Zamata quits 'SNL' after four seasons

Attorneys general from Pennsylvania and Texas led the litigation.